NCT03931304View on ClinicalTrials.gov

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2)

CompletedOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

July 31, 2018

Study Completion Date

September 30, 2018

Conditions
Peritoneal CarcinomaOvarian Cancer
Interventions
PROCEDURE

Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy procedure

Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy procedure

Trial Locations (1)

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03931304 - Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2) | Biotech Hunter | Biotech Hunter